A Methodological Framework for the Efficient Characterization of Peripheral Nerve Stimulation Parameters.
Rachel S Jakes, Benjamin J Alexander, Vlad I Marcu...
https://pubmed.ncbi.nlm.nih.gov/40661284/Actively Recruiting
Led by Jennifer Sweet, MD · Updated on 2025-07-16
12
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating a novel system designed to help people with severe arm paralysis, known as tetraplegia, caused by diseases or injuries like spinal cord injury or stroke. This system combines small electrodes implanted in the brain areas controlling movement and sensation with electrodes on the upper arm and shoulder to stimulate paralyzed muscles. The goal is to measure intended movements through brain signals and stimulate muscles accordingly to restore arm and hand function. This is an open-label, exploratory safety and feasibility study enrolling up to 12 participants. The study involves surgical implantation of the Reconnecting the Hand and Arm to the Brain ReHAB System, which includes brain-computer interface BCI and functional electrical stimulation FES components. After implantation, participants will undergo research sessions over 13 months to test and adjust the device. Following this period, participants can choose to remove the device or continue in a long-term extension study lasting up to 5 years. Participants will be closely monitored through frequent visits and evaluations during the 13-month testing phase. Researchers will assess safety by tracking treatment-related adverse events and measure functional improvements using tasks such as brain-controlled cursor movement, activities of daily living tests, and grasp-release tasks. Participants must be available for ongoing follow-up and may allow video recordings of procedures and evaluations. The trial aims to determine the safety, tolerability, and potential effectiveness of this combined brain and muscle stimulation approach for restoring arm and hand movement.
CONDITIONS
An Early Feasibility Study of the ReHAB System
J
Jennifer Sweet, M.D.
M
Mario Beccera, RN
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Jennifer Sweet, MD
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Investigational BCI + FES Device | Current Rehabilitation Standard |
|---|---|---|
| What it is | A surgically implanted system combining brain-computer interface technology and functional electrical stimulation, designed to decode neural signals and deliver stimulation to restore upper-limb movement. | Established rehabilitation therapies for chronic tetraplegia, including physical and occupational therapy, and standard functional electrical stimulation systems used to improve or maintain upper-limb movement. |
| Primary use | To enable restoration of upper extremity function in adults with chronic tetraplegia, aiming to decode brain signals and deliver stimulation for purposeful hand and arm movement. | To improve or maintain functional movement of the hand and arm through targeted exercises, adaptive techniques, and stimulation in chronic tetraplegia management. |
| How it is given or performed | The device is surgically implanted, with BCI sensors placed and FES electrodes interfaced with computer processing. Participants undergo regular research sessions for testing and programming over a 13-month period. | Therapy is delivered through routine clinical sessions by rehabilitation therapists, sometimes supplemented by surface FES devices attached externally. Sessions focus on structured exercises, adaptive methods, and functional task practice. |
| Evidence status | Early feasibility trial; results not yet established. Safety and performance of the implanted BCI+FES device are under investigation. | Longstanding published evidence supports improved hand and arm function with guideline-based therapy and established FES systems for suitable individuals with chronic tetraplegia. |
| Important limitations | The device requires surgical implantation, dedicated caregiver support, frequent visits, and stability for 13 months. Only adults meeting strict medical and psychosocial criteria are eligible. Clinical outcomes and long-term risks remain unestablished. | Functional gains with standard rehabilitation may plateau despite therapy; external FES devices can be limited by factors such as muscle fatigue, access, and insurance coverage. Recovery is often slow and incomplete. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery plus immediate recovery period
Participants undergo surgical implantation of the ReHAB System components including brain-computer interfaces and functional electrical stimulation devices.
1 surgical visit followed by several immediate post-operative visits
Duration - 13 months
Participants engage in testing and use of the ReHAB System over a 13-month period to assess device safety, tolerability, and efficacy in restoring arm and hand movement.
Frequent research sessions during the 13-month testing period
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DEVICE_FEASIBILITY
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Rachel S Jakes, Benjamin J Alexander, Vlad I Marcu...
https://pubmed.ncbi.nlm.nih.gov/40661284/Rachel S Jakes, Benjamin J Alexander, Vlad Marcu...
https://pubmed.ncbi.nlm.nih.gov/41022103/Eric Z Herring, Emily L Graczyk, William D Memberg...
https://pubmed.ncbi.nlm.nih.gov/37162904/Jennifer Sweet, MD
Lead Sponsor